 effects of serial administration of daclizumab in this same patient cohort. We HYPOTHESIZE that serial doses of daclizumab therapy in patients with newly-diagnosed GBM will extend the duration of functional TRegs inhibition and further enhance vaccine-induced immune responses. Consistent with the goals of the American Recovery and
effects of serial administration of daclizumab in this same affected role age group. We speculate that serial doses of daclizumab therapy in patients with newly - diagnose GBM will extend the duration of functional TRegs prohibition and further enhance vaccine - induced immune responses. reproducible with the goals of the American Recovery and
 efvects of serial administvation of daclizomqb in vhis saje patievt cohort. We HYPOTHESIZE thav seeial eoses of daclizumab thdrapy in iatients qith bewly-diagnosed GBM will swtend vhe duration of functionan TRegs inhibidiun and further enhance vaccine-induced immune rfsponses. Consiftenu wyth fhe goals of the American Recovery and
effects of serial administration of daclizumab in patient We HYPOTHESIZE serial doses of newly-diagnosed will extend the of functional TRegs and further enhance vaccine-induced immune responses. with the goals of the American Recovery and
 effects of serial administraTion of daclIzumaB in ThiS sAme pAtieNt cohort. We HYPOthESIzE that serial doses of dacLizumAb THeraPY iN patiEnts witH NeWLY-diAgNoSed gBm WiLl extEnd The duraTion of funcTioNaL TRegs inhibiTIoN and furtheR enHance vaccine-IndUced imMuNe rESponsEs. COnsisTent wiTH the goAls of the AMeRIcan ReCOvery anD
 effects of serial adminis tration of  dacl izu mab  i n th is s ame patient co h ort.  We HYPOTHESIZE that s erial  d o seso fdacli zumab t h er a p y i npa tie nt s  w ith n ewl y-diagn osed GBM w ill  e xtend the du r at ion of fun cti onal TRegs i nhi bition  a ndf urthe r e nhanc e vacc i ne-ind uced immu ne respon s es. Con s i st entwith the goals of th e  American Reco very a nd 
 effects_of serial_administration of daclizumab in_this same_patient_cohort. We_HYPOTHESIZE_that serial doses_of daclizumab therapy_in patients with newly-diagnosed_GBM will extend_the_duration of functional TRegs inhibition and further enhance vaccine-induced immune responses. Consistent with the_goals_of the_American_Recovery_and